Bicodon bias can determine the role of synonymous SNPs in human diseases by McCarthy, Christina Beryl et al.
McCarthy et al. BMC Genomics  (2017) 18:227 
DOI 10.1186/s12864-017-3609-6
RESEARCH ARTICLE Open Access
Bicodon bias can determine the role of
synonymous SNPs in human diseases
Christina McCarthy1,2,3, Alejandra Carrea1,2 and Luis Diambra1,2*
Abstract
Background: For a long time synonymous single nucleotide polymorphisms were considered as silent mutations.
However, nowadays it is well known that they can affect protein conformation and function, leading to altered
disease susceptibilities, differential prognosis and/or drug responses, among other clinically relevant genetic traits.
This occurs through different mechanisms: by disrupting the splicing signals of precursor mRNAs, affecting regulatory
binding-sites of transcription factors and miRNAs, or by modifying the secondary structure of mRNAs.
Results: In this paper we considered 22 human genetic diseases or traits, linked to 35 synonymous single nucleotide
polymorphisms in 27 different genes. We performed a local sequence context analysis in terms of the ribosomal
pause propensity affected by synonymous single nucleotide polymorphisms. We found that synonymous mutations
related to the above mentioned mechanisms presented small pause propensity changes, whereas synonymous
mutations that were not related to those mechanisms presented large pause propensity changes. On the other hand,
we did not observe large variations in the codon usage of codons associated with these mutations. Furthermore, we
showed that the changes in the pause propensity associated with benign sSNPs are significantly lower than the pause
propensity changes related to sSNPs associated to diseases.
Conclusions: These results suggest that the genetic diseases or traits related to synonymous mutations with large
pause propensity changes, could be the consequence of another mechanism underlying non-silent synonymous
mutations. Namely, alternative protein configuration related, in turn, to alterations in the ribosome-mediated
translational attenuation program encoded by pairs of consecutive codons, not codons. These findings shed light on
the latter mechanism based on the perturbation of the co-translational folding process.
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Background
Recent advances in sequencing and genotyping technolo-
gies have allowed the association of pathological traits
or diseases with common genetic variants observed in
human populations. As a result of genome-wide associa-
tion studies (GWASs), a large number of human diseases
have been associated with single nucleotide polymor-
phisms (SNPs). These small genetic variants can occur in
gene-coding regions or in non-coding regions (introns or
intergenic regions). SNPs in a coding region can result
in a codon that encodes a different amino acid (missense
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mutation) or in a premature stop signal (nonsense muta-
tion). Depending on the position and/or the chemical
properties of the replaced amino acid, thesemutations can
lead to nonfunctional proteins, causing human genetic
diseases such as epidermolysis bullosa [1], sickle-cell ane-
mia [2], mandibuloacral dysplasia [3], SOD1-mediated
amyotrophic lateral sclerosis [4] and cancer [5, 6], among
others. Due to the degeneracy of the genetic code (i.e.,
the existence of more codons than the number of different
amino acids and stop signals), a SNP does not necessarily
change the amino acid sequence of a translated protein.
These types of substitutions are known as synonymous
SNPs (sSNPs) and, for a long time, they were consid-
ered as silent mutations because it was assumed that
they had no phenotypic consequences. However, strong
evidence currently supports the fact that synonymous
codons have phenotypic consequences, and the notion
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that sSNPs are innocuous has dramatically changed in
the last decade. Synonymous mutations can lead to dis-
ease by means of four known mechanisms [7]. One of
them is by disrupting splicing signals which, in turn,
results in the loss, or gain, of one or more gene-coding
regions [8–10]. Another mechanism affects the regulatory
binding-sites of transcription factors and miRNAs [11].
For example, Crohn’s disease is caused by synonymous
variant rs10065172 within the IRGM coding region, which
alters a miR-196 binding site [12]. In the third mechanism,
synonymous mutations can change the secondary struc-
ture of mRNA causing low protein expression levels. An
emblematic example of the latter is the sSNP rs769223.
This mutation results in a more stable mRNA molecule,
but in lower levels of the COMT protein, leading to higher
pain sensitivity [13]. The fourth alternative consists in an
alteration of the ribosome-mediated translational attenu-
ation program (i.e., a decrease in the translational rate due
to ribosomal pauses) which alters protein conformation
(Fig. 1a). In this sense, there is strong evidence supporting
the fact that synonymous codons are not always trans-
lated in the same manner. On the contrary, some of them
are translated faster and/or more accurately than others.
There are many studies suggesting that ribosomal pauses
schedule co-translational folding of protein domains, and
determine the final protein conformation [14–24]. This
means that sSNPs can alter the ribosome-mediated trans-
lational attenuation program with noticeable impact on
the final protein configuration and function. This could
certainly lead to pathological phenotypes when consider-
ing clinically important proteins. In this regard, it has been
observed that the drug-transport pump MDR1 protein
changes its substrate specificity as a consequence of the
sSNP rs1045642 [14], leading to multidrug resistance in
cancer cells [25]. Similarly, recently it was proved that the
kinetics of co-translational folding (and translation) of the
gamma-B crystallin protein is controlled by synonymous
codon usage [18].
Despite building evidence which suggests that synony-
mous codons could be a subliminal code for protein
folding [26–29], the operating mechanism for such a sec-
ondary code remains poorly understood. To understand
how sequences can control the ribosome-mediated trans-
lational attenuation program, it is convenient to review
the degeneracy of the genetic code. This redundancy
offers a lot of degrees of freedom to codify proteins.
Nevertheless, organisms use or explore an insignificant
fraction of these available possibilities. This fact is a con-
sequence of many biological constraints (such as protein
expression levels, ribosomal proofreading errors, protein
solubility, folding accuracy, protein stability) operating
to optimize how to convey the correct message from
genes to functional proteins. As a consequence of these
constraints, there are selective pressures that promote a
biased usage of synonymous codons [30, 31]. Since the
recruitment of a charged tRNA to the codon in the A-
site depends on the abundance of each tRNA [32–35],
there is a generalized idea that codon usage can mod-
ulate translational rates. Another way to modulate the
translational rate consists of the non-Watson-Crick (wob-
ble) interactions, since they are usually associated with
higher dissociation rates between the mRNA and the
decoding center [36]. Nevertheless, transcript translation
is a sequential process in which ribosomes synthesize
proteins. At each proofreading step the ribosome coor-
dinates several simultaneous or successive tasks, such as
the recruitment of a charged tRNA to the codon in the
A-site, the assembly of the new residue to the nascent
polypeptide, the translocation of the tRNA-mRNA com-
plex, the dissociation of the empty tRNA from the mRNA,
and its release from the E-site. Thus, the translational
rate is the result of several concomitant processes with
different kinetics. In particular, the dissociation process
of the mRNA codon from the decoding center has been
described as a rate-limiting one [37]. This implies that
attenuation of the translational rate not only occurs when
the ribosome awaits the entry of scarce tRNA into the
A-site, but also during the mRNA translocation process.
Consequently, it can be expected that selective pressure
operates beyond codon usage. In fact, recent genome-
wide statistical analyses have revealed that bicodons, i.e.,
pairs of consecutive codons, are also subject to evolution-
ary pressure, and biased bicodon usage has been reported
as well [38, 39]. More recently, a genome-wide statisti-
cal analysis revealed that some bicodons are overused in
sequences associated with highly abundant proteins, but
underused when they code for lowly abundant proteins
[40]. The opposite situation was also observed, as there
are bicodons which are frequently used to codify lowly
abundant proteins, but underused in sequences that code
for highly abundant ones [40]. Based on the statistical
analysis of bicodon usage in sequences associated with
lowly or highly abundant proteins, the author estimated a
pause propensity measure of all bicodons, and proposed
that alternative protein configurations could be associated
with alterations in the translational attenuation program
encoded by bicodons (Fig. 1b).
In the light of these previous findings, in this work
we reexamined several human genetic diseases associated
with sSNPs (compiled by Sauna et al. [41]), by means
of computing the relative change in the pause propen-
sity measure due to synonymous bicodon change. We
also made the comparison with a similar measure based
on the codon frequency usage, and found that in many
cases the diseases of Sauna’s list can be better explained
by an alteration of the ribosome-mediated translational
attenuation program encoded by bicodons rather than
by codons. Finally, we showed that the changes in the
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Fig. 1 Ribosome-mediated translational attenuation program and bicodons. a Graphical representation of how a sSNP can alter the
ribosome-mediated translational attenuation program and, ultimately, final protein conformation. Consequently, this can affect protein function
leading to pathological phenotypes. b Simplified graph showing codons (green boxes) and bicodons (red ellipses) within an mRNA sequence. Owing
to the superposition of bicodons, each codon is part of two different bicodons in a given open reading frame. Alterations of the ribosome-mediated
translational attenuation program, with the resulting alternative protein conformations and functions, could be encoded by bicodons, rather than
by codons
pause propensity of the sSNPs related to diseases are
significantly greater than the pause propensity changes
associated with clinically benign sSNPs.
Results
Bicodon bias in the human genome
Since we proposed that synonymous mutations pro-
grammed by bicodons can result in alterations in the tim-
ing of co-translational folding (which in turn can lead to
pathological phenotypes), in this work we focused on the
mechanism by which translational rate, and consequently
co-translational folding too, are altered due to ribosomal
pauses. In a previous article we related bicodon sequences
to their pause propensities, by means of counting bicodon
occurrence in coding sequences associated with highly
or lowly abundant proteins. For illustrative purposes,
Fig. 2a depicts the frequency distributions associated
with the bicodons that encode the amino acid pair SK.
These distributions were computed using sequences from
the low protein abundance (PA) sample (red bars), and
from the high PA sample (orange bars). While bicodons
TCAAAA, TCAAAG and TCGAAG have similar fre-
quency usage in both sequence samples (low and high
PA), many other bicodons have an evident preference for
sequences related to low or high PA. In particular, the
bicodons TCCAAG and AGCAAG have a high preference
for coding proteins associated with low and high abun-
dance, respectively. As shown in [40], the observed bias in
bicodons cannot be explained by codon usage. This leads
to questions concerning the selective forces that drive this
bicodon bias.
Considering that sequences which codify highly abun-
dant proteins need to be optimized in terms of transla-
tional rate, we have interpreted this bias by assigning a
key role to bicodons in programming translation pauses of
the ribosomal machinery. Using the occurrence frequency
in each sequence sample, we have computed the pause
propensity measure π for each bicodon, and applied the
Fisher’s exact test to asses the statistical significance of
the usage bias. In addition, we have also computed the
residual score χ2, defined in [42], which indicates when
the observed bicodon bias can be explained, or not, by
the codon usage bias. Notice that while π expresses a
degree of the preference of a given bicodon for coding low
PA sequences instead of high PA sequences, the p-value
provided by Fisher’s exact test is the probability against
the null hypothesis of equal distribution in both sequence
samples. The latter can be more influenced by the num-
ber of observations rather than by the net difference of
bicodon occurrence between samples. Figure 2b depicts
a raster plot between π and the p-value. Note that, for
a better visualization, the signed log[ p-value] has been
plotted.
This figure also shows that a high preference (i.e.
high |π |), not necessarily implies a low p-value. How-
ever, some bicodons present a significant preference for
coding low (red balloon) or high PA sequences (orange
balloon).
Figure 2c depicts two raster plots of the residual scores
χ2 versus the pause propensity and the p-values for all
bicodons. Large values of the residual score (χ2 > 5)
indicate that the observed bias in the bicodon cannot be
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Fig. 2 Relationship between synonymous bicodons, protein abundances (PA) and pause propensity. a Frequency distributions associated with the
bicodons that encode the amino acid pair SK, computed using sequences from the low PA sample (red bars), and from the high PA sample (orange
bars). Some bicodons are more frequent within lowly abundant proteins (such as TCCAAG), some within highly abundant ones (such as AGCAAG),
and other bicodons have similar frequencies in both groups of proteins (such as TCAAAA, TCAAAG and TCGAAG). b Raster plot of the p-values versus
the pause propensity for all bicodons. To improve the visualization of this correlation we plot −S log10[ p-value] instead of p-value, where S takes the
values +1 or −1 when the bicodon has preference for sequences with low or with high PA, respectively. c Raster plot of the residual scores χ2
versus the pause propensity and p-values for all bicodons. Small pause propensity values (orange zone) are related to bicodons with high PA,
whereas large pause propensity values (red zone) are related to bicodons with low PA. Green lines represent the nine synonymous bicodon variants
for the SK amino acid pair that involve a large change in pause propensity (π ≥ 0.754)
explained by codon usage [42]. Our working hypothesis
is that bicodons with high values of the pause propensity
measure, such as bicodon TCCAAG, could be linked to
ribosomal pauses (red zone in Fig. 2c). A synonymous
bicodon variant consists of a change in one or more
nucleotides of the hexanucleotide, that still codifies for
the same amino acid pair. When one of these variants
changes the associated pause propensities, it can alter
the translational attenuation program leading to protein
misfolding and dysfunction. In the case of our particular
example, the amino acid pair SK can be codified by 12
synonymous bicodons, allowing 66 alternative synony-
mous bicodon variants. Nine of such synonymous variants
(green lines in Fig. 2c) involve a relative large change in
the pause propensity (π ≥ 0.754). Among these, there
is only one that corresponds to a single point mutation:
the mutation AGTAAG ↔ AGCAAG (with π = 0.14
and π = -0.90, respectively, which represents a change
of π = 1.04). These bicodons have an associated p-
value of 0.065 and 0.003, respectively, which means that
the preference of bicodon AGCAAG for coding highly
abundant proteins is significant. On the other hand,
none of the synonymous bicodon variants for the KS
amino acid pair involve a large change in the pause
propensity. Codon usage bias per se cannot explain the
lack of symmetry between amino acid pairs SK and KS,
as well as with many other pairs, because both pairs have
the same codons but in a different order. An analysis of
all possible 420 amino acid pairs (including residue:stop)
results in that there are 26718 synonymous bicodon
variants, 8497 of which correspond to sSNPs. Figure 3a
displays a histogram of the pause propensity variation
of all possible synonymous bicodon variants associated
with the sSNPs. Figure 3b depicts the associated Z-score,
or quantile function, where the red region indicates the
highest 10% pause propensity variation, i.e., those sSNPs
with a pause propensity variation larger than π = 0.754.
A similar Z-score which was calculated for the measure
based on the codon frequency usage is depicted in the
Additional file 1: Figure S1.
McCarthy et al. BMC Genomics  (2017) 18:227 Page 5 of 11
Fig. 3 Pause propensity variation and Z-score. a Histogram of the pause propensity variation of synonymous bicodon variants associated with
sSNPs. b Associated Z-score. The red region indicates the highest 10% pause propensity variation, i.e., those sSNPs with a pause propensity variation
larger than π = 0.754
Analysis of pathological and benign sSNPs in humans
Sauna et al. compiled a list of synonymous mutations in
human genes that significantly correlate with 22 human
diseases [41]. This compilation only includes those sSNPs
that have a significant association with disease or a clini-
cal trait. One of these, the multidrug resistance case, has
been confirmed to be associated to changes in protein
conformation due to alterations in the translational atten-
uation program [14]. It is also known that the underlying
mechanisms of Crohn’s disease, cystic fibrosis, and tem-
poromandibular joint disorder (TMD) are not related to
alterations of the translational attenuation program. On
the other hand, in the remaining 18 diseases the reason
why the sSNPS lead to pathological conditions remains
unknown. In this paper, we analyzed the local sequence
context of each compiled sSNP, by computing the pause
propensity change due to the sSNP in both bicodons
affected by the variation. The results of this analysis are
summarized in Table 1, and further details of our analy-
sis for each disease are given in Additional file 2: Text and
Additional file 3: Table S1.
We found that the variations of the pause propensity
measure associated with the corresponding sSNPs, are
low in the case of the following diseases: Crohn’s dis-
ease, cystic fibrosis and TMD; whereas it is high in the
multidrug resistance case, in perfect agreement with the
known mechanisms of these diseases. Performing the
same analysis for the remaining 18 diseases with unknown
subjacent mechanisms, we found that 14 of these have
large associated changes (Z-score ≥ 0.80) in the pause
propensity due to the sSNPs in one or more bicodon
variants, in at least one of the genes implicated in the
disease. We also observed that the affected bicodons
are associated with a significant usage bias, as deter-
mined by Fisher’s exact test. For comparison we also
computed a similar measure based on codon frequencies,
the differential relative synonymous codon usage (RSCU).
In contrast with previous observations, the differential
RSCU only shows large changes in the case of cervical
and vulvar cancer (rs2069763), schizophrenia (rs6277), in
agreement with the bicodon analysis, and Crohn’s dis-
ease (rs10065172), where a large change in the pause
propensity is not expected because, in this case, the
sSNP is related to alterations in the miR-196 binding site
[12]. Furthermore, the p-value provided by Fisher’s exact
test associated with codons does not vary significantly
(Additional file 3: Table S1). These results add sugges-
tive evidence supporting the hypothesis that sSNPs that
do not alter splicing processes neither mRNA structure,
but are associated with diseases, could be involved in the
alteration of the ribosome-mediated translational attenu-
ation program. Moreover, this attenuation program could
be more related to bicodons than to codons. On the other
hand, we did not observe large changes in the pause
propensitymeasure for the remaining four diseases, which
could be indicating that they are not associated with alter-
ations of the ribosome-mediated translational attenuation
program. However, we found that in two of them, asthma
and cervical and vulvar cancer, the corresponding sSNPs
introduce rare bicodons in place of more frequent ones.
In particular, in the case of asthma (rs2069763), the fre-
quency usage of the GATAGC bicodon over both samples
sequences, is 6-fold smaller than GACAGC, while in the
case of cancer (rs2069763), the frequency usage of the
CTGCTG bicodon is 4-fold higher than the frequency
usage of CTTCTG. As these bicodons are not frequent in
both the low and high PA samples, we are not able to relate
this rareness with the ribosome-mediated translational
attenuation program, or with other known mechanisms
that lead to a pathological condition. However, it would
seem that bicodon frequency could be an indicator of the
sSNP pathogenicity. Finally, in the case of non-small-cell
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Table 1 Pause propensity variation due to sSNPs linked to clinically relevant genetic diseases or traits
Disease/trait Gene rsID Bicondon change Z-score
from to bicodon codon
Macular degeneration CFHR5 rs34533956 GACGTG GATGTG 0.91 0.51
Longevity TERT rs33954691 CACGCA CATGCA 0.84 0.71
rs33959226 GCAGAG GCGGAG 0.83 0.55
Asthma SLC6A7 rs2240794 GATAGC GACAGC 0.11 0.51
Pul. sarcoidosis CARD15 rs1861759 GTGCGT GTGCGG 0.99 0.17
Tuberculosis TIRAP rs7932766 GCCTAC GCTTAC 0.74 0.62
Cystic Fibrosis CFTR rs1800092 ATCATC ATAATC 0.09 0.17
Coeliac disease CD44 rs1071695 CACGTG CATGTG 0.84 0.71
APIP rs1571133 ACACTT ACCCTT 0.32 0.39
Crohn’ disease IRGM rs10065172 CTGATG TTGATG 0.77 0.93
Smoking-related cancer NBS1 rs709816 GATGCA GACGCA 0.80 0.51
rs1061302 AATCCA AATCCG 0.79 0.47
Colorectal cancer ERCC1 rs11615 AATGTG AACGTG 0.97 0.07
Chronic myeloid leukemia WT1 rs2229069 CGCACG CGCACA 0.80 0.24
rs2227985 CAGGAA CAGGAG 0.69 0.10
Non-small-cell lung carcinoma EGFR rs2293347 ACAGAC ACAGAT 0.48 0.51
Cervical & vulvar cancer IL2 rs2069763 CTGCTG CTTCTG 0.49 0.80
Drug resistance ABCB1 rs1045642 ATTGTG ATCGTG 0.94 0.55
CHRNA4 rs1044396 CCGAGC CCGAGT 0.26 0.74
Alzheimer COX6B1 rs7991 AAGACC AAGACT 0.84 0.36
COX6C rs1130569 TACGAT TATGAT 0.59 0.24
COX8A rs61759492 ATCATG ATAATG 0.83 0.17
ADHD NTF3 rs6332 CAGCCG CAGCCA 0.46 0.47
Huntington ADORA2A rs5751876 GGCTAT GGCTAC 0.99 0.24
PADI2 rs2076615 GGTGGC GGGGGC 0.93 0.77
Schizophrenia SYNGR1 rs74681509 ACCTTC ACCTTT 0.84 0.36
DRD2 rs6277 ACTCCC ACTCCT 0.95 0.82
rs6275 CACCAT CACCAC 0.81 0.71
TMD COMT rs769223∗ GCGAGG GCAAGG 0.67 0.55
rs1121923 GTGGCC GTAGCC 0.89 0.13
Type III rs248 GAGTTT GAATTT 0.34 0.10
hyperlipidemia LPL rs45607438 CATGTT CACGTT 0.89 0.71
rs316 AAGACC AAGACA 0.91 0.39
Chronic hepatitis C IRF7 rs1061501 CGGGAT CGAGAT 0.84 0.17
Osteoporosis CD44 rs11033026 CATGAG CATGAA 0.93 0.10
We computed the Z-score associated to the change in the pause propensity values, or to the change in the differential RSCU, as a consequence of single nucleotide mutations
in a subset of 22 human diseases or traits selected from [41]. The first column lists the diseases/traits, the following columns list the affected genes, the rs IDs, the bicodon
changes, and Z-scores. Only the variant associated with larger Z-score is listed, for a more complete table, please see Additional file 3: Table S1. ∗ is validated by HapMap
lung cancer and attention-deficit/hyperactivity disorder
(ADHD), our local sequence context analysis did not show
alterations associated with these sSNPs.
To further analyze synonymous mutations which cor-
relate with human diseases, we also performed our local
sequence context analysis for sSNPs which have been clas-
sified clinically as benign, as a control test. The results of
this analysis are summarized in Additional file 4: Table S2.
These results indicate that benign sSNPs have an asso-
ciated lower change in the pause propensity measure,
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compared to sSNPs which we have associated to alter-
ations of the ribosome-mediated translational attenuation
program. In this sense, we used the Mann-WhitneyU test
to analyze the difference in pause propensities between
pathological and benign sSNP groups. This test identi-
fied significant differences between both groups (p-value
=0.0022). In contrast, a similar analysis with the differ-
ential codon usage did not identify significant differences
between both groups (p-value =0.41).
Even though we found significant differences in the
pause propensities values between pathological and
benign sSNP groups, some benign sSNPs (like rs11797,
rs2242244, and rs2272068, among others) have large alter-
ations of their pause propensities (see Additional file 4:
Table S2). This could mean that a large value of π
might be a necessary condition for an alteration of the
translational attenuation program. However, this is not a
sufficient condition to associate a sSNP with a disease.
Discussion
Genetic diversity allows populations to adapt to environ-
mental changes, making them less prone to extinction.
From a clinical point of view, such genetic variability
also underlies the distinctive susceptibility of organisms
to diseases and their differential sensitivity to toxins or
drugs. SNPs are the most common form of such diver-
sity, and account for much of the variation in genetic traits
between individuals. It was originally thought that sSNPs
had no implications on human health. Nevertheless, this
concept has radically changed in the last ten years, since
it was shown that the supposed ’silent’ mutations can
have an impact on human health through various mech-
anisms. One of these mechanisms is protein misfolding,
which occurs by means of an alteration of the ribosome-
mediated translational attenuation program [15]. It was
demonstrated that this mechanism operates in the mis-
folding of membrane protein Pgp encoded by the ABCB1
gene [14], in conformational changes in the FRQ pro-
tein of Neurospora [43], in the SufI protein of E. coli [17],
and in the bovine gamma-B crystallin [18]. However, it is
not known how widespread this mechanism is among the
ensemble of clinically relevant genetic traits or diseases.
The main idea underlying the protein-misfolding based
mechanism, is that codon usage can modulate ribo-
some traffic and, consequently, co-translational folding,
by means of associating frequent codons with fast elon-
gation rates and rare codons with slow elongation rates.
However, the exact mechanism connecting proteostasis
with codon usage remains unclear. Recently it was sug-
gested that ribosome translocation from the codon in
the P-site to the codon in the A-site depends on both
codons, and not only on the codon in the A-site [40].
Consequently, the ribosome-mediated translational atten-
uation program would be encoded by bicodons, rather
than by single codons. The author defined a pause propen-
sity measure based on the preference of each bicodon
to encode sequences associated with highly abundant or
lowly abundant proteins.
In the light of this new concept, in this article we
reviewed 22 genetic diseases or traits associated with syn-
onymousmutations. It is known that the genetic condition
for multidrug resistance is a consequence of the protein-
misfolding based mechanism [14], whereas three other
of these 22 diseases (Crohn’s disease, cystic fibrosis and
TMD) are the result of different mechanisms. Neverthe-
less, the underlying mechanisms of the remaining diseases
or traits are still unknown.
Conclusions
Our results, based on the variation of the pause propen-
sities associated with the corresponding sSNPs, are in
agreement with the underlyingmechanism of the four dis-
eases with known causes. Regarding the other 18 diseases,
we have found that 14 of them could be explained by one
or more alterations in the translational attenuation pro-
gram in at least one of the genes implicated in the disease.
These alterations, which are results of the sSNPs, con-
sist in large changes in the pause propensity associated
with bicodons. We have found that these changes are sig-
nificantly greater than those related to clinically benign
sSNPs. However, a large change in the pause propensity
does not necessarily lead to a misfolded protein, even less
so to a pathological condition. A pathological condition
will be determined by how the function of the protein
is affected, and by the role of the pause on protein fold-
ing, among others. On the other hand, we have found that
differential RSCU has similar values in both pathological
and benign sSNP groups. This suggests that synonymous
codons could have a secondary role in determining trans-
lational pauses, in any case derived from the bicodons that
they form.
We believe that the findings presented here, even
though preliminary, shed light on genetic diseases asso-
ciated with sSNPs whose underlying mechanism is based
on protein misfolding due to a modification of the trans-
lational attenuation program encoded in bicodons. Future
experimental studies will test our predictions helping to
understand the role of bicodon preferences in proteostasis
in a more conclusive manner.
Methods
The methodology that was used in this work comprised
two steps: (i) the computation of the p-value provided
by the Fisher’s exact test, the residual score and the
pause propensity for all bicodons from human coding
sequences; and (ii) the computation of the pause propen-
sity variation, and the associated Z-score function, due
to the sSNPs linked to each human genetic disease
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considered here. In our study, we have considered a list
of genetic human diseases linked to sSNPs compiled by
Sauna et al. [41]. This list comprises 50 sSNPs that have
significant association with diseases, but does not include
sSNPs with literature reports that identified both syn-
onymous and non-synonymous mutations. From this list,
we only considered those SNPs which are validated by
1000Genomes, and also rs769223 which is validated by
HapMap. This excluded 15 sSNPs from our study, yield-
ing 35 sSNPs in 27 genes related to 22 clinically rele-
vant genetic traits. Additional details of the sSNPs listed
in Table 1 can be found in Additional file 3: Table S1.
Futhermore, we also selected all those sSNPs from single
nucleotide polymorphism database (dbSNP) [44], which
are clinically classified as benign, have been validated by
1000Genomes project, and have a minor allele frequency
(MAF) greater than 0.05. We found 87 sSNPs following
these criteria. Further details are listed in Additional file 4:
Table S2.
Computation of Fisher’s exact test, residual score and
pause propensity
The first step for this computation was previously devel-
oped in [40]. Briefly, the computation consisted of the
frequency count of each bicodon in two samples of cod-
ing sequences, one sample associated with lowly abun-
dant proteins and the other sample associated with highly
abundant proteins. The sequences constituting each sam-
ple were selected according to their abundance, based
on the genome-wide protein abundance database (Paxdb)
[45, 46]. The nucleotide coding sequences correspond-
ing to the selected proteins were downloaded from the
Ensembl web site [47]. Next, we computed bicodon occur-
rences oXij over all coding sequences belonging to a given
sample X, where index i denotes the codon correspond-
ing to the P-site, while j denotes the one corresponding
to the A-site. After this, we used Fisher’s exact test to
examine whether the number of occurrences of bicodons,
oLij, observed in the sequence sample associated with
low PA, was significantly different than the number of
occurrences observed in the high PA sample oHij . The p-
values of all bicodons are depicted in heat map fashion
in Additional file 5: Figure S2. To improve visualization,
colors are related to the signed log[ p-value], i.e., the quan-
tity −S log10[ p-value], where S takes the values +1 or −1
depending on the preference of the bicodon for low or
high PA sequences, respectively.
We also computed the residual score for each bicodon
by removing the contribution due to the bias in codons











, (the ∗ indicates that the sum is
only over bicodons that encode the same amino acid pair
encoded by the bicodon ij). eij is the expected number of
occurrences of each bicodon given by eij = fifjNp/N2tot ,
where fi is the number of occurrence of single codons i,
Ntot is the total number of codons in the set of sequences,
and Np is the number of bicodons. We compute the resid-
ual score of each bicodon over low and high PA sample
sequences separately, and will be denoted by χ2L and χ2H ,
respectively. Thus, we use the total residual score χ2ij =
χ2L +χ2H to assess whether the usage bias in bicodon ij can
explained by usage bias in codons i and j.
Besides p-values provided by Fisher’s exact test and
residual scores χ2, we also defined a pause propensity
measure π that takes the differential frequency usage of
bicodons in each sample sequences into account. This
measure can be understood in terms of the RSCU index
introduced by [48]. RSCU index is defined as RSCUi =
s fi/Na. Where s is the number of codons encoding the
same amino acid, Na is the frequency of that amino
acid, and fi is the frequency of the codon i within the
human genome. When RSCUi is greater, or lower, than
1, this indicates that codon i is over-, or under-, repre-
sented in the genome, respectively. Thus, we defined the
pause propensity measure π as the difference between the
relative synonymous bicodon usage computed over the
sequence sample associated with low PA, (RSBUL), and
the one computed over the sequence sample associated
with high PA, (RSBUH ). Mathematically,
πij = RSBULij − RSBUHij = q

f Lij − f Hij

/Nap. (2)
Here, f Xij is the frequency of the bicodon ij computed
over the sequence sample X, q is the number of bicodons
encoding the same amino acid pair, and Nap is the fre-
quency of that amino acid pair within the human genome.
Thus, a large, or small, value of πij indicates the prefer-
ence of bicodon ij for coding low, or high, PA sequences,
respectively. The values of π , p-value, and χ2 for all
bicodons are listed in Additional file 6: Table S3.
For the sake of comparison, we computed a similar
measure to π but now in terms of codon frequency. We
denoted it as differential RSCU

i.e., RSCULij − RSCUHij

.
We also performed Fisher’s exact test for codons. The
latter allowed us to examine whether the number of occur-
rences of codons observed in the low PA sample, was sig-
nificantly different to the number of occurrences observed
in the high PA sample.
In our study we have not considered triplets of codons.
We believe that the codon associated with the E-site may
have low or none effect on ribosomal transit, because
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this site is not involved in the translocation of the tRNA-
mRNA complex. Furthermore, if triplets were to be con-
sidered it would be necessary to increase the number
of sequences in our samples to a prohibitive size, which
would result in poor statistical measures.
Pause propensity variation of genetic human diseases
There are two bicodon variations associated with one
SNP. This occurs because as each SNP takes part in one
codon, it can be part of two different bicodons, as indi-
cated in Fig. 1b. For each variation, bicodoni → bicodonf ,
we computed the pause propensity variation π = πf −
πi. To assess the statistical significance of this variation
we computed a Z-score, also known as the inverse cumu-
lative distribution function. For each probability p in
the probability distribution of a random variable X, this
score function assigns value x for which Prob(X ≤
x) = p [49]. To this end, we computed π for 8497
synonymous bicodon variants associated to single point
mutations. Figure 3 depicts the histogram of π , where
the right panel depicts the associated Z-score. The red
region indicates the highest 10% pause propensity varia-
tion, i.e., those sSNPs with a pause propensity variation
larger than π = 0.754. A similar Z-score function
was computed for the differential RSCU obtained for
codons. Additional file 1: Figure S1, depicts the asso-
ciated Z-score function for codons. The Z-score values
for bicodons and codons associated with the studied
sSNPS are listed in the last column of Tables S1 and S2.
These tables also list the relative change of the p-value
defined as the ratio (pvf − pvi)/pvi, where pvi and pvf
are the signed log [ p-value] of bicodon i and bicodon f ,
respectively.
Additional files
Additional file 1: Figure S1. Z-score function associated with the
differential RSCU change of all the synonymous codon variants. The red
region indicates the highest 10% pause propensity variation, i.e., those
sSNPs with a variation larger than 0.28. (PDF 13 kb)
Additional file 2: Text. Additional details for each disease or clinical trait
listed in Table 1, such as basic background, references, accession number
and local sequence context analysis. (PDF 88 kb)
Additional file 3: Table S1. Genetic diseases and sSNPs. The first column
corresponds to the disease or genetic trait. The second and third columns
correspond to the associated gene and SNP (where both can be more than
one), respectively. Each SNP affects only one codon (third SNP row), but
two bicodons, when the mutation is in the P-site (first SNP row), and when
the mutation is in the A-site (second SNP row). Fourth, fifth, sixth and
seventh columns, refer to the starting bicodon, list the bicodon sequence,
the p-value, the residual score (χ2 = χ2L + χ2H) and π value, respectively.
The following four columns, refer to the resulting bicodon, list the bicodon
sequence, the log-transformed p-value, the residual score and π value,
respectively. The following three columns enumerate the relative p-value,
the pause propensity variation, π , and the corresponding Z-score due to
the synonymous bicodon variant. The last two columns contain a
summarized result of our analysis for each disease and the related
references. (XLS 41 kb)
Additional file 4: Table S2. Silent sSNPs. First and second columns
correspond to benign sSNPs and their associated genes respectively. Each
SNP affects only one codon (third SNP row), but two bicodons, when the
mutation is in the P-site (first SNP row), and when the mutation is in the
A-site (second SNP row), but only one codon (third SNP row). Third, fourth,
fifth and sixth columns, refer to the starting bicodon, list the bicodon
sequence, the p-value, the total residual score (χ2 = χ2L +χ2H) and π value,
respectively. The following four columns, refer to the resulting bicodon, list
the bicodon sequence, the log-transformed p-value, the χ2 score value
and π value, respectively. The last three columns enumerate the relative
p-value, the pause propensity variation, π , and the corresponding
Z-score due to the synonymous bicodon variant. (XLS 66 kb)
Additional file 5: Figure S2. Pause propensity heat map. The color of
each cell is determined by the pause propensity π of the associated
bicodons. Columns represent codons corresponding to P-site, while rows
represent codons corresponding to A-site, so that each cell in the heat map
represents a bicodon. Red cells indicate bicodons with the highest pause
propensity value (low PA preference), while blue cells indicate bicodons
with the lowest pause propensity value (high PA preference). Rows and
columns have been clustered to improve visualization. (PDF 260 kb)
Additional file 6: Table S3. Statistical features of 3904 bicodons in the
human genome. The first column corresponds to the amino acid pair (∗
symbolizes stop codon), the second column to the corresponding
bicodon, the third and fourth columns list the number of occurrences of
bicodons in the low and high PA samples, respectively. The fifth and sixth
columns correspond to the residual scores χ2L and χ
2
H computed over the
low and high PA samples, respectively. The last two columns correspond
to the signed log[ p-value] and the pause propensity values of each
bicodon, respectively. (XLS 587 kb)
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